Table 3.

Adjusted hazard ratios^* for incident myocardial infarction, stroke, chronic kidney disease, or congestive heart failure comparing ACE-I^† vs. Beta-blocker second line initiation (N=15,532^‡)

Incident :	Number of events	Adjusted hazard ratio* ACE-I vs. BB§	95% CI	p value
Myocardial Infarction	96	1.05	(0.69, 1.58)	0.83
Stroke	101	1.01	(0.68, 1.52)	0.95
Congestive Heart Failure	23	1.71	(0.69, 4.23)	0.25
Chronic Kidney Disease∥	1,445	0.95	(0.85, 1.05)	0.33

^*adjusted by inverse propensity score weights

^†ACE-I: angiotensin-converting enzyme inhibitor

^‡eight persons missing initial blood pressure measurements or comorbidity information

^§BB: beta-blocker

^∥additionally adjusted for eGlomerular Filtration Rate (N=14,080)